参加者的心声


"I think your conference is one of the best ones focused on immunogenicity.  Your ability to attract multiple FDA speakers is a big plus."

- CSO, Selecta Biosciences

 

I think this is one of the best meetings in the field for immunogenicity and appreciate that experts in the field from industry, academia, and regulatory are brought together into one small forum. The talks and breakout sessions were very informative.
- Principal Scientist, Process Development, Amgen, Inc.

 “The immmunogenicity summit is one of the highlights of the year for me.”
- Biotech Quality and Immunogenicity Reviewer, Biotechnology Products, CDER-FDA

 

“This event has a great atmosphere for networking and learning about new expectations in our always changing field.”

- Senior Group Leader, Immunogenicity PPD, Inc.

 

“Allows open discussion with colleagues from other companies and with regulators.”
Associate Director, Biomarkers and Clinical Bioanalysis, Translational Medicine and Early Development, Sanofi

“High quality speakers and interesting topics.”
- Director and Head, Project Support for New Biological Entities, Quantitative Pharmacology and Drug Disposition, EMD Serono

 

“Always an excellent meeting for measuring the pulse of the industry and gaining insight about trends and challenges from thought leaders and regulators alike.”
- Research Scientist, Immunology, Charles River Labs Preclinical Services, Montreal Inc.

 

“Very good interaction and Q&A between participants; Informal interactions which allow the sharing of more information than can be raised in a talk.”
- Senior Director, Immunogenicity Assessment, Biomarin Pharmaceutical Inc.

 

"I really enjoyed the conference. There were quite a few FDA attendees that made themselves available for informal conversations and interactions. In general, there seemed to be a good balance between formal presentations and informal interactions."
-  Senior Director, Immunogenicity Assessment, Biomarin Pharmaceutical Inc.

 

“Thank you for wonderful sessions.”
- Medicinal Safety Research, Daiichi-Sankyo

 

“Has the right people with the right talks which promotes constructive conversations and perhaps future collaborations.”
- Post-Doctoral Fellow, Molecular Biology, National Cancer Institute

 

“I really liked the wide and deep background provided by the highly specialized speakers. Everyone in the field should attend this class.”
- Post-Doctoral Fellow, Molecular Biology, National Cancer Institute

 

 “This is the highlight of this conference: wonderful talks.”
- Group Leader, R&D, Promega

 

“It was a very interesting meeting with an excellent level”.
- Head, R&D, UDIBI IPN

 

“Great workshop; good coverage of the background info, also lots of case studies and examples from the clinic.”
- Scientist, Contract Assay Services, Stem Cell Technologies

 

“It was great to have the opportunity to talk at the CHI meeting.  I thought the meeting was really well attended and also had a great range on speakers on key topics.”
- Staff Scientist, BioAnalytical Sciences, Genentech, Inc.

 

“As always, it was a fantastic event with respect to both the content and the networking opportunities.”
- Associate Professor, Thayer School of Engineering, Dartmouth

 

“High quality content in different assay formats and technologies for immunogenicity assessment."
- Senior Research Associate, Bioanalytical, Cliantha Research Ltd. 

 

 “Interesting new data; very relevant to the field."
- Senior Scientist, Process Development, Amgen, Inc.

 

"The topics discussed were important, and the speakers were excellent". 
- Senior Director, Non-clinical Development, Versatis

Choose your language
Chinese
Japanese
Korean
English






免费电子邮件通知服务